NM_172107.4:c.1229dupC

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_172107.4(KCNQ2):​c.1229dupC​(p.Pro411AlafsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000712 in 1,403,696 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P410P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

KCNQ2
NM_172107.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 1.09

Publications

1 publications found
Variant links:
Genes affected
KCNQ2 (HGNC:6296): (potassium voltage-gated channel subfamily Q member 2) The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and a related protein encoded by the KCNQ3 gene, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 1 (BFNC), also known as epilepsy, benign neonatal type 1 (EBN1). At least five transcript variants encoding five different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KCNQ2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • neonatal encephalopathy with non-epileptic myoclonus
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neonatal-onset developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • seizures, benign familial neonatal, 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • seizures, benign familial neonatal, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign familial neonatal-infantile seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign neonatal seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-63424194-C-CG is Pathogenic according to our data. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63424194-C-CG is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 422786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ2NM_172107.4 linkc.1229dupC p.Pro411AlafsTer7 frameshift_variant Exon 11 of 17 ENST00000359125.7 NP_742105.1 O43526-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ2ENST00000359125.7 linkc.1229dupC p.Pro411AlafsTer7 frameshift_variant Exon 11 of 17 1 NM_172107.4 ENSP00000352035.2 O43526-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.12e-7
AC:
1
AN:
1403696
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
692626
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32198
American (AMR)
AF:
0.00
AC:
0
AN:
35852
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25190
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79550
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49220
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5698
European-Non Finnish (NFE)
AF:
9.25e-7
AC:
1
AN:
1081114
Other (OTH)
AF:
0.00
AC:
0
AN:
58184
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Jan 16, 2017
Eurofins Ntd Llc (ga)
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KCNQ2: PVS1, PM2, PP4, PS4:Supporting -

Mar 26, 2022
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -

Jun 30, 2021
Revvity Omics, Revvity
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Seizures, benign familial neonatal, 1 Pathogenic:2
-
Génétique des Maladies du Développement, Hospices Civils de Lyon
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 17, 2020
Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Pathogenic:1
Feb 21, 2018
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1229dupC pathogenic mutation, located in coding exon 11 of the KCNQ2 gene, results from a duplication of C at nucleotide position 1229, causing a translational frameshift with a predicted alternate stop codon (p.P411Afs*7). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -

Developmental and epileptic encephalopathy Pathogenic:1
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Pro411Alafs*7) in the KCNQ2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ2 are known to be pathogenic (PMID: 14534157, 23692823, 27779742). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KCNQ2-related conditions. ClinVar contains an entry for this variant (Variation ID: 422786). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.1
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886041339; hg19: chr20-62055547; API